Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: Comparison with superparamagnetic iron oxide-enhanced MR imaging

Journal of Magnetic Resonance Imaging

Volumn 20, Issue 5, 2004, Pages 826-837

  Kim, Young Kon ^a   Kim, Chong Soo ^a   Kwak, Hyo Sung ^a   Lee, Jeong Min ^b,c  

^a Chonbuk National University Medical School   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

Contrast media; Liver, MR; Liver, neoplasms; Magnetic resonance (MR); MR, fast scan techniques

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GADOBENIC ACID; GLOBULIN; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; ARTICLE; CANCER SURGERY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEPATITIS B; HUMAN; IMAGE QUALITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; THREE DIMENSIONAL IMAGING;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; IRON; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS; OXIDES; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 7044270842     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20188     Document Type: Article

References (27)

1. Gaa J, Halabu H, Jenkins RL, Finn JP, Edelman RR. Liver masses: replacement of conventional T2-weighted spin-echo MR imaging with breath-hold MR imaging. Radiology 1996;200:459-464.
2. Fujita T, Honjo K, Ito K, Matsumoto T, Matsunaga N, Hamm B. High-resolution dynamic MR imaging of hepatocellular carcinoma with a phased-array body coil. Radiographics 1997;17:315-331.
3. Madore B, Pelc NJ. SMASH and SENSE: experimental and numerical comparisons. Magn Reson Med 2001;45:1103-1111.
4. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for last MRI. Magn Reson Med 1999;42:952-962.
5. Weiger M, Pruessmann KP, Kassner A, et al. Contrast-enhanced 3D MRA using SENSE. J Magn Reson Imaging 2000;12:671-677.
6. Weiger M, Pruessmann KP, Boesiger P. Cardiac real-time imaging using SENSE. Magn Reson Med 2000;43:177-184.
7. Golay X, Pruessmann KP, Weiger M, et al. PRESTO-SENSE: an ultrafast whole-brain fMRI technique. Magn Reson Med 2000;43:779-786.
8. Yoshioka H, Takahashi N, Yamaguchi M, Lou D, Saida Y, Itai Y. Double arterial phase dynamic MRI with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinomas. J Magn Reson Imaging 2002;16:259-266.
9. Takahashi N, Yoshioka H, Yamaguchi M, Saida Y, Itai Y. Accelerated dynamic MR imaging with a parallel imaging technique for hypervascular hepatocellular carcinomas: usefulness of a test bolus in examination and subtraction imaging. J Magn Reson Imaging 2003;18:80-89.
10. Ros PR, Freeny PC, Harms SE, et al. Hepatic MR imaging with ferunioxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995;196:481-488.
11. Choi D, Kim SH, Lim JH, et al. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus combined CT during arterial portography and CT hepatic arteriography. AJR Am J Roentgenol 2001;176:475-482.
12. Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996;200:785-792.
13. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999;212:876-884.
14. Kim SH, Choi DI, Lim JH, et al. Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences. Korean J Radiol 2002;3:87-97.
15. Fretz CJ, Elizondo G, Weissleder R, Hahn PF, Stark DD, Ferrucci JT. Superparamagnetic iron oxide-enhanced MR imaging: pulse sequence of optimization for detection of liver cancer. Radiology 1989;172:393-397.
16. Chakraborty DP, Winter LH. Free-response methodology: alternate analysis and a new observer-performance experiment. Radiology 1990;174:873-881.
17. Metz CE. ROC methodology in radiological imaging. Invest Radiol 1986;21:720-733.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:150-174.
19. Altman DG. Statistics in medical journals: developments in the 1980s. Stats Med 1991;10:1897-1913.
20. Sodickson DK, Manning WJ. Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn Reson Med 1997;38:591-603.
21. Yoshimitsu K, Honda H, Jimi M, et al. Correlation of three-dimensional gradient echo dynamic MR imaging with CT during hepatic arteriography in patients with hypervascular hepatocellular carcinomas: preliminary clinical experience. J Magn Reson Imaging 2001;13:258-262.
22. Murakami T, Kim T, Takamura M, et al. Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 201;218:763-767.
23. Yu JS, Kim KW, Kim EK, Lee JT, Yoo HS. Contrast enhancement of small hepatocellular carcinoma: usefulness of three successive early image acquisitions during multiphase dynamic MR imaging. AJR Am J Roentgenol 1999;173:597-604.
24. Carlson J, Crooks L, Ortendahl D, Kramer DM, Kaufman L. Signal-to-noise ratio and section thickness in two-dimensional versus three-dimensional Fourier transform MR imaging. Radiology 1988;166:266-270.
25. Frahm J, Haase A, Matthaei D. Rapid three-dimensional MR imaging using the FLASH technique. J Comput Assist Tomogr 1986;10:363-368.
26. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32:780-796.
27. Schneider G, Maas R, Schultee Kool L, et al. Low-dose gadobenate dimeglumine versus standard dose gadopentelate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison. Invest Radiol 2003;38:85-94.